🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/04/2013 | 43,31 | 43,78 | 42,95 | 43,24 | -0,09% | 1,92% | 14.637.835 |
| 03/04/2013 | 42,94 | 44,05 | 42,94 | 43,28 | +1,00% | 2,58% | 27.114.066 |
| 02/04/2013 | 42,47 | 42,94 | 42,39 | 42,85 | +1,26% | 1,30% | 13.400.252 |
| 01/04/2013 | 41,98 | 42,34 | 41,77 | 42,32 | +0,34% | 1,36% | 10.377.191 |
| 28/03/2013 | 42,03 | 42,28 | 41,95 | 42,18 | +0,23% | 0,79% | 17.440.502 |
| 27/03/2013 | 42,11 | 42,22 | 41,90 | 42,08 | -0,65% | 0,77% | 11.497.503 |
| 26/03/2013 | 41,94 | 42,37 | 41,89 | 42,36 | +1,60% | 1,14% | 12.694.110 |
| 25/03/2013 | 41,94 | 41,98 | 41,52 | 41,69 | -0,48% | 1,11% | 13.746.721 |
| 22/03/2013 | 41,85 | 42,09 | 41,79 | 41,89 | +0,25% | 0,71% | 10.463.232 |
| 21/03/2013 | 42,01 | 42,16 | 41,76 | 41,78 | -0,75% | 0,95% | 12.476.021 |
| 20/03/2013 | 41,98 | 42,26 | 41,87 | 42,10 | +0,96% | 0,93% | 15.693.066 |
| 19/03/2013 | 41,70 | 41,83 | 41,60 | 41,70 | +0,16% | 0,55% | 16.248.297 |
| 18/03/2013 | 41,77 | 41,93 | 41,57 | 41,63 | -1,04% | 0,85% | 12.699.350 |
| 15/03/2013 | 41,82 | 42,07 | 41,78 | 42,07 | -0,41% | 0,68% | 25.499.831 |
| 14/03/2013 | 42,66 | 42,70 | 41,60 | 42,24 | -0,72% | 2,57% | 27.136.283 |
| 13/03/2013 | 42,50 | 42,68 | 42,44 | 42,55 | -1,00% | 0,56% | 18.781.418 |
| 12/03/2013 | 43,34 | 43,34 | 42,82 | 42,98 | +3,16% | 1,19% | 58.695.860 |
| 11/03/2013 | 40,98 | 41,67 | 40,91 | 41,66 | +1,61% | 1,86% | 40.492.729 |
| 08/03/2013 | 41,41 | 41,51 | 40,95 | 41,00 | -0,69% | 1,34% | 30.678.418 |
| 07/03/2013 | 41,81 | 41,92 | 41,12 | 41,29 | -0,94% | 1,92% | 14.392.813 |
| 06/03/2013 | 41,32 | 41,74 | 41,09 | 41,68 | +0,99% | 1,57% | 19.301.121 |
| 05/03/2013 | 41,60 | 41,65 | 41,13 | 41,27 | -0,21% | 1,26% | 15.843.769 |
| 04/03/2013 | 40,95 | 41,36 | 40,80 | 41,36 | +1,67% | 1,37% | 14.839.890 |
| 01/03/2013 | 40,39 | 40,72 | 40,39 | 40,68 | -0,23% | 0,80% | 15.527.482 |
| 28/02/2013 | 41,04 | 41,23 | 40,77 | 40,77 | -0,56% | 1,12% | 14.893.442 |
| 27/02/2013 | 40,33 | 41,17 | 40,33 | 41,00 | +1,30% | 2,08% | 13.537.121 |
| 26/02/2013 | 40,79 | 40,84 | 40,17 | 40,48 | -0,24% | 1,64% | 14.570.449 |
| 25/02/2013 | 41,33 | 41,46 | 40,56 | 40,57 | -1,05% | 2,17% | 20.338.850 |
| 22/02/2013 | 40,63 | 41,29 | 40,58 | 41,00 | +1,11% | 1,74% | 16.132.807 |
| 21/02/2013 | 40,55 | 40,62 | 40,33 | 40,55 | -0,38% | 0,71% | 12.390.504 |